Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapy.

May S, Kurmoo F, Iliffe M, David J, Patel A, Wiselka M, Stephenson I, Delahooke T, Lai FY, Dustan S, Tang JW.

J Infect. 2020 Feb 1. pii: S0163-4453(20)30035-9. doi: 10.1016/j.jinf.2020.01.011. [Epub ahead of print] No abstract available.


DNA extraction columns contaminated with murine sequences.

Erlwein O, Robinson MJ, Dustan S, Weber J, Kaye S, McClure MO.

PLoS One. 2011;6(8):e23484. doi: 10.1371/journal.pone.0023484. Epub 2011 Aug 18.


HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.

Duda A, Lee-Turner L, Fox J, Robinson N, Dustan S, Kaye S, Fryer H, Carrington M, McClure M, McLean AR, Fidler S, Weber J, Phillips RE, Frater AJ; SPARTAC Trial Investigators.

J Virol. 2009 Feb;83(3):1228-39. doi: 10.1128/JVI.01545-08. Epub 2008 Nov 19.


Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.

Fox J, Hill S, Kaye S, Dustan S, McClure M, Fidler S, Mackie NE.

AIDS. 2007 Jan 11;21(2):237-9.


Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.

Frater AJ, Edwards CT, McCarthy N, Fox J, Brown H, Milicic A, Mackie N, Pillay T, Drijfhout JW, Dustan S, Clarke JR, Holmes EC, Zhang HT, Pfafferott K, Goulder PJ, McClure MO, Weber J, Phillips RE, Fidler S.

J Virol. 2006 Jul;80(14):7226-34.


Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.

Mackie N, Dustan S, McClure MO, Weber JN, Clarke JR.

J Virol Methods. 2004 Aug;119(2):73-8.


Supplemental Content

Loading ...
Support Center